Cvs Pharmacy #06085 Durable Medical Equipment & Medical Supplies Location: 10554 Loveland Madeira Rd, Loveland, Ohio 45140 Phone: (513) 683-0400 |
Walgreens #03792 Durable Medical Equipment & Medical Supplies Location: 9520 Fields Ertel Rd, Loveland, Ohio 45140 Phone: (513) 583-9273 |
Walgreens #6191 Durable Medical Equipment & Medical Supplies Location: 10529 Loveland Madeira Rd, Loveland, Ohio 45140 Phone: (513) 683-5615 |
Kroger Pharmacy #413 Durable Medical Equipment & Medical Supplies Location: 800 Loveland Madeira Rd, Loveland, Ohio 45140 Phone: (513) 677-3400 |
Kroger Pharmacy #14435 Durable Medical Equipment & Medical Supplies Location: 6388 Branch Hill Guinea Pike, Loveland, Ohio 45140 Phone: (513) 697-4720 |
Walgreens #9636 Durable Medical Equipment & Medical Supplies Location: 6385 Branch Hill Guinea Pike, Loveland, Ohio 45140 Phone: (513) 697-6574 |
Meijer Pharmacy #150 Durable Medical Equipment & Medical Supplies Location: 3911 W State Route 22-3, Loveland, Ohio 45140 Phone: (513) 583-2100 |
Premier Pain Treatment Institute- L Medicare Supplier Location: 1301 Mattec Dr, Loveland, Ohio 45140 Phone: (513) 454-7246 |
News Archive
In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.
Research with baboons at the Texas Biomedical Research Institute may help explain why some people who take bone-strengthening drugs like bisphosphonates are at-risk for atypical fractures in the long bones in their legs.
The November 2010 issue of the Archives of Physical Medicine and Rehabilitation, Official Journal of the American Congress of Rehabilitation Medicine, has published a set of 9 articles on traumatic brain injury (TBI) that will accelerate future research in the field by establishing common language for the degree of injury, how it is measured and classified, treatment and potential outcomes.
At two Food and Drug Administration meetings, Sidney H. Schnoll, MD, PhD, Vice President, Pharmaceutical Risk Management Services of PinneyAssociates, will discuss the need for predictability, feasibility and transparency to ensure that Risk Evaluation and Mitigation Strategies benefit patient safety and public health.
› Verified 5 days ago